Abstract
Collagen is the major structural component of cartilage and mutations in the genes encoding Type XI collagen are associated with severe skeletal dysplasias including Fibrochondrogenesis and Stickler syndrome, and with early onset osteoarthritis. Using a zebrafish mutant for col11a2 we test the impact of loss of Type XI collagen on cell behaviour and mechanical performance in the developing skeleton.
We show that in col11a2 mutants Type II collagen is made but is prematurely lost from maturing cartilage and ectopically expressed in the joint. Using Atomic Force Microscopy, we show that skeletal tissues (cartilage and bone) are stiffer in mutant zebrafish. We also observe wider joints with less defined interzones in mutants, which impacts on the function of the joint. Using Finite Element Analyses we model the mechanical performance of wild type and mutant joint shape and material properties; demonstrating that changing joint shape has a greater impact on the pattern of skeletal strain than material properties. Finally, we show that heterozygous carriers of the col11a2 mutation reach adulthood but are susceptible to severe, early onset, osteoarthritis. Taken together our data demonstrates a key role for Type XI collagen in maintaining the properties of cartilage matrix; which when lost leads to alterations to cell behaviour that give rise to joint pathologies.
Introduction
Articular cartilage is a highly specialised connective tissue, which provides a smooth, lubricated surface for articulation and load transmission with low joint friction. Collagen is a major constituent of cartilage, accounting for around 75% of its dry weight (1). Type II collagen makes up 90-95% percent of the collagen network, while the remaining 5-10% is comprised of other collagens such as Type IX and XI, with studies of chick articular cartilage showing association of these three collagen types in a tight D-periodic array (2,3) These minor collagens help to organise and stabilize the Type II collagen fibril network that, along with proteoglycans, water and other proteins, form a dense extracellular matrix (ECM) in which chondrocytes are dispersed (4). The tight fibrillar structure from collagens and the water content, from interaction with glycosaminoglycans (GAGs), govern the mechanical properties of the cartilage. Type XI collagen belongs to the fibril-forming class of collagens; it is formed as a heterotrimer of three chains each encoded by a different gene: COL11A1 (5), COL11A2, and COL2A1(6,7). While the α1 chain of Type XI collagen is expressed in both cartilaginous and ocular tissue, the α2 chain is predominantly expressed in cartilage.
Given the close interaction between Type II and Type XI collagens, mutations that affect either can cause similar destabilization of cartilage organisation, as observed in Marshall Stickler Syndrome. Stickler syndrome, which affects around 1 in 7500 new-borns, encompasses a hereditary group of conditions caused by defective Type II, IX or XI Collagen (8) and is divided in to three phenotypes: depending on the collagen mutation present. Type III is associated with mutations to the Type XI gene COL11A2 (9) (10). Type III Stickler syndrome is characterised by skeletal, orofacial, and auditory abnormalities including: scoliosis; hearing loss; cleft palate; joint hypermobility; (11), multiple hereditary exostoses (10), and premature osteoarthritis (OA) in 75% of patients before the age of 30 (8). The majority of mutations linked to Stickler syndrome lead to truncated proteins lacking the c-terminal domain of the peptide, disturbing the association of the alpha helices to form procollagens and consequentially the formation of collagen fibrils and fibres (12). Mutations in genes encoding Type XI collagens are also associated with other skeletal dysplasias, including the severe developmental condition Fibrochondrogenesis (13), and Weissenbacher-Zymuller syndrome (9).
Mutant mice for Col11a1 (Cho-/-), are neonatally lethal and show decreased limb bone length, cleft palate and short snouts (14), and thicker, less uniform collagen fibrils in the cartilage ECM (15). Type II collagen degradation (16) and early onset OA were reported in Cho/+ heterozygous mice (17). Additionally, mice haploinsufficient for Col11a1 display altered susceptibility to load induced damage (18). While Col11a2 mutant mice have been reported to show hearing loss, their skeletal phenotype has not been described (19). The interaction of Type XI collagen with Type II is important for the maintenance of the spacing and diameter of Type II collagen fibrils. As Type II collagen is the major collagen in cartilage, changes to its organisation can impact the mechanical performance of the cartilage. Computational modelling has shown that spacing and interconnectivity between collagen fibrils has a significant effect on the mechanical performance of cartilage (20). Cartilage is an intrinsically mechanically sensitive tissue, and changes to cartilage biomechanical performance have been extensively described during development (21), ageing and disease (22).
Zebrafish are an attractive model for studying the effect of genetic lesions on skeletal development. The larvae are translucent which, twinned with fluorescent reporter transgenic lines, enables dynamic imaging of skeletal cells (23,24) and the development of the zebrafish craniofacial skeleton is well documented (25–27). The zebrafish jaw joint is synovial (28) and requires mechanical input to form normally (29,30).
Here, we show that larval zebrafish carrying a col11a2 mutation display a variety of phenotypes including alterations to: joint shape, cartilage composition, cell organisation and the material properties of the cartilage during development. These changes impact on the biomechanical and functional performance of the joint. The mutant fish go onto to display phenotypes consistent with Stickler syndrome such as altered face shape and early onset osteoarthritis. Taken together these data suggest that mechanical and cellular changes to the developing skeleton explain the predisposition of people with mutations in Type XI Collagens to early onset osteoarthritis.
Methods
Zebrafish husbandry and transgenic lines
Zebrafish were maintained as described previously (31), all experiments were approved by the local ethics committee and performed under a UK Home Office Project Licence. Transgenic lines Tg(col2a1aBAC:mcherry) (32) and Tg(smyhc1:GFP) (33), have been described previously. col11a2sa18324 mutant zebrafish have a C>A base pair change at position 228, leading to a premature stop codon in the triple helical domain of the α2 chain of collagen XI.
Wholemount immunohistochemistry
Performed as previously described (32). Primary antibodies and dilutions used were: rabbit pAb to collagen II, (abcam ab34712), 1:500; mouse pAb to collagen II, (DHSB II-II6B3), 1:500, rabbit pAb to collagen I, (abcam ab23730), 1:100. Secondary antibodies were Dylight 488 or 550 (Thermo Scientific) used at a dilution of 1:500. For imaging, larvae were mounted ventrally in 1% agarose and imaged on a Leica SP5 confocal microscope with a 10x objective.
3D render generation, joint measurements and quantification of extoses
3D volume renders, surface models and measurements were acquired using Amira 6.0 (FEI). Surface models were generated manually by segmenting jaw joints using the segmentation tool. Measurements, as depicted in Figure 1C-D and 3A were taken using the 3D perspective measurement tool. To better visualise exostoses, 3D volume renders were created, and the grayscale range of colour applied. Extoses were quantified in each lower jaw element from single confocal image stacks in ImageJ (34) using the multi-point tool.
A, B) Ventral and lateral images of wild type (wt) (A) and col11a2 homozygous mutant (col11a2-/-) (B) larvae immunostained for Type II collagen at 3, 5 and 7dpf. White arrows = changes to collagen distribution (Meckel’s cartilage (MC), palatoquadrate (PQ), ceratohyal (C) and hyosymplectic (HS)) Dashed insets = regions of reduced deposition at higher magnification (white asterisks mark Type II collagen maintenance, red asterisks mark fragments of degraded Type II collagen, red arrows show IOM ligament). Scale bar = 100μm. C, D) Young’s modulus values for (C) immature and hypertrophic chondrocytes in wt (n=7) and col11a2-/- (n=9) cartilage at 7dpf and (D) adult bone in wt (n=8) and col11a2-/- (n=6). Inset = location of AFM measurements in larvae (white box = immature chondrocytes, red box = hypertrophic chondrocytes). Student’s unpaired t-tests were performed for C and D, data is mean with SEM.
Measurement of jaw displacement and movement frequency
High-speed movies were made of jaw movements in wt and col11a2 mutants; frames corresponding to maximum jaw displacements were selected, imported into ImageJ and the difference, in μm, between resting and open states at points shown in Figure 5A recorded. The number of mouth movements in 1000 frames was recorded from 7 wild type (wt) and 7 col11a2 mutant fish as previously described in (30).
Live imaging of transgenic fish
Live larvae at 5dpf were anaesthetised in 0.1mg/ml MS222 and mounted ventrally in 0.3% agarose with tricaine prior to being imaged on a Leica SP5II confocal microscope with a 10x objective. The number of slow muscle fibres was quantified manually in ImageJ from confocal images of double transgenic Tg(smyhc1:GFP);(Col2a1aBAC:mcherry) zebrafish at 5dpf.
Alcian blue and alizarin red staining
5dpf and 7dpf wt and col11a2 mutant larvae were stained following a previously described protocol (35) and imaged on a Leica MZ10F stereo microscope prior to genotyping.
In situ hybridisation
In situ hybridisation was performed as described (36) using a previously described col11a2 probe (37). Larvae were imaged on GXM-L3200 B upright microscope.
Nanoscale surface morphology and Young’s Moduli
Atomic Force Microscopy (AFM) was performed on adult (1 year) bone and larval (7dpf) cartilage from wt and col11a2 mutant fish. A multi-mode VIII AFM with Nanoscope V controller and PeakForce control mechanism were used and the force-curves measured for means of set-point control in the PeakForce system and analysed in real-time to provide quantitative nanomechanical mapping (QNM) of the samples. QNM analysis was conducted with both Nusense SCOUT cantilevers [NuNano, Bristol, UK], (nominal tip radius 5 nm, spring constants 21 – 42 N m-1) and RTESPA-300 cantilevers [Bruker, CA, USA], (nominal tip radius 8 nm and spring constants 30 – 60 N m-1), whilst high resolution imaging of topographic features was conducted using SCANASYST-AIR-HR cantilevers [Bruker, CA, USA] (nominal tip radius of 2 nm). The system was calibrated for measurement of Young’s modulus (YM) fitting with DMT models, using the relative method and samples of known YM (highly oriented pyrolytic graphite (HOPG) (18 GPa) and PDMS-SOFT-1-12M (2.5 MPa) [Bruker, CA, USA]), for bone and cartilage measurements respectively. Bone was investigated in ambient environment whilst cartilage was maintained in a hydrated state post-dissection to minimise structural changes from drying. A root-mean-square (RMS) mean was calculated for 65536 measurements taken over a 500 nm × 500 nm region, 3 repeats were performed per sample; repeated on 3 fish per genotype.
Micro-Computed Tomography (μCT)
Adult fish were fixed in 4% PFA for 1 week followed by sequential dehydration to 70% ethanol. Heads were scanned using an XT H 225ST micro-CT scanner (Nikon) with a voxel size of 5 μm, x-ray source of 130 kV, 53 μA and without additional filters. Images were reconstructed using CT Pro 3D software (Nikon).
Histology
3 1-year old col11a2 +/- and 3 wild types, were decalcified in 1M EDTA solution for 20 days. Samples were dehydrated in ethanol, embedded in paraffin and sagittally sectioned at 8 μm, relevant joint sections were de-waxed and stained with 1% Alcian blue 8GX (pH 2.5, then counterstained with Haematoxylin and Eosin. We adapted the OARSI cartilage OA histopathology grading system (38) to grade severity of OA. PicroSirius red staining was performed using 0.1% Sirius red F3B in saturated aqueous Picric acid, washed in acidified water, dehydrated and mounted under coverslips with DPX, then imaged using polarising filters.
Finite Element (FE) models
Representative confocal z-stacks of 7dpf wt or mutant larvae were selected. Cartilage elements were segmented in Scan IP using Otsu segmentation (Supplemental Figure 2A), then a solid geometry created using the interpolation and 3D wrap tool. Smoothing filters (recursive Gaussian at 1px3) were used on the meshes to blend any rough small element clusters.
Cartilage geometry close to the joint was separated from the main cartilage in a duplicate mesh using the 3D editing tool allowing us to assign different material properties to hypertrophic chondrocytes and immature chondrocytes (Supplemental Figure 2B). The mesh of the cartilage near the joints was subtracted from the original cartilage mesh using a Boolean operation. The meshes were added to a model and each part assigned their respective elastic isotropic material properties based on AFM measurements; values in Supplemental Figure 2, Table 1.
A, B) Ventral and lateral views of alizarin red/ alcian blue staining show glycosaminoglycans in cartilage (blue) and mineralisation (red) in wt (A) and col11a2-/- (B) at 5 and 7dpf. Red asterisks = bone formation. BA = branchial arches, OC = otic capsule, OP = operculum, CL = cleithrum, PS = parasphenoid, NT = notochord tip, O = otoliths. Scale bar = 200μm. C, D) Jaw shape quantification (n=3 for all). Location of measurements above graphs. Student’s unpaired t-tests used in C and D, data is mean with SEM.
The models were imported into Abaqus and 2 steps created: 1 to simulate jaw closure and 2 for jaw opening. Boundary conditions were applied to these steps, with the jaw constrained in all axes of motion at the ceratohyal to anchor it in space, and in y and z at the base of the palatoquadrate. Muscle forces, direction of opening/closure and muscle attachment points were as previously described (39). The datum tool in Abaqus was used to create a custom rectangular datum coordinate system for each muscle; then used as the coordinate system for force direction between each muscle’s insertion and origin to ensure force travelled along the same vector from one end to the other. A job was created and executed for the model, and the output analysed for stress, strain and displacement.
DNA extraction and genotyping
Fins were clipped from anaesthetised or fixed zebrafish and incubated in base solution (25 mM NaOH,0.2 mM EDTA) before the addition of neutralisation solution (40 mM Tris HCl, Ph5.0). For genotyping we used KASP (LGC) genotyping or μCR followed by Sanger sequencing (col11a2 F-GGTGGCCTGATTCTGACCA; col11a2 R-TATCTCACACCAGGATGCCG).
Results
col11a2 and col2a1 are co-expressed in the zebrafish lower jaw
To establish the extent of col11a2 expression in cartilage we performed in situ hybridisation in larval zebrafish. Strong col11a2 expression could be seen throughout the craniofacial cartilages including the Meckel’s cartilage, palatoquadrate, ceratohyal and ethmoid plate (Supplementary Figure 1A). The expression pattern of col11a2 overlapped the expression of the Type II collagen gene col2a1a visualised with the Tg(col2a1aBAC:mCherry) reporter zebrafish (Supplementary Figure 1B). The domains of col11a2 and col2a1a expression, as expected, preceded expression of the mature Type II protein, visualised by immunostaining, such that immature cells at the jaw joint and Meckel’s symphasis express col11a2 and col2a1a RNA but not the mature Type II protein (Supplementary Figure 1C).
col11a2 mutants show atypical type II collagen deposition, resulting in alterations to skeletal material properties
As Type XI collagen has previously been reported in the core of Type II collagen fibrils (3) and is thought to have a role in the stability of Type II collagen (40), we wanted to test whether loss of col11a2 in zebrafish would impact Type II collagen stability. We crossed the col11a2sa18324 mutant into the col2a1a:mCherry transgenic reporter to visualise expression of col2a1a and studied the expression in craniofacial cartilages from 3-7dpf. We saw no differences in the position, timing or extent of col2a1 expression between mutants and their siblings suggesting that loss of col11a2 has no impact on the expression of col2a1a (Supplementary Figure 2). We next used immunostaining to detect Type II collagen protein in mutant and wild type (wt) larvae. At 3dpf we could not detect any differences between wt and mutant larvae (Figure 1A, B). However, by 5dpf clear differences in the distribution of Type II collagen were seen in the lower jaw (Figure 1A, B). Whereas in wt fish Type II collagen surrounded each chondrocyte in the lower jaw cartilages, in mutants protein expression was concentrated in the perichondrium and was reduced between chondrocytes. Concomitant with this reduction of protein in the more mature matrix towards the middle of the cartilage elements, small pieces of immunostained material were seen detached from the main elements (Figure 1B), We also observed ectopic expression of Type II collagen in the ligament (Figure 1B). A pronounced reduction and disorganisation of Type II collagen became clear by 7dpf (Figure 1B) and was more obvious in the cartilages that make up the lower jaw, with the lateral cartilage of the ear more preserved (Figure 1A, B). Taken together these data suggest that expression and synthesis are unaffected by loss of col11a2, but that it does impact on maintenance of Type II collagen protein.
To test whether loss of Type II collagen led to changes to the material properties of the cartilage, we performed atomic force microscopy (AFM) on dissected lower jaw cartilages from 7dpf wt and mutants. We tested the properties in regions containing immature cells close to the jaw joint and Meckel’s symphasis (Figure 1C) and observed a significant increase in Young’s modulus (YM) from an average of 4.15 to 7.4 MPa (Figure 1C). In more mature, intercalated cells towards the centre of the Meckel’s cartilage (in which we saw loss of Type II collagen) the difference in YM was around 4 times greater than that of comparable regions in wt (Figure 1C). This suggests that loss of Type II collagen as a result of the col11a2 mutation leads to stiffening of the cartilage ECM. As we observed altered material properties in larvae at pre-skeletonised stages we wanted to test whether this would persist to adulthood and impact bone properties. We dissected operculae from wt and mutant fish and used AFM to establish YM. As in the larval cartilage, we observed that the bone from col11a2 mutant fish had a significantly higher YM than siblings (Figure 1D).
Type II collagen is not replaced by GAGs or Type I collagen in col11a2 mutant zebrafish
As Type II Collagen was prematurely lost from maturing chondrocytes, we sought to examine whether glycosaminoglycans (GAG)s, were similarly reduced. We stained wt and mutant larvae with Alcian blue (to mark cartilage GAGs) and Alizarin red (to mark bone) at 5 and 7dpf. We saw no reduction of GAG reactivity in the mutants at 5 or 7dpf (Figure 2A, B). Additionally, we saw no dramatic changes to bone formation, with dermal and chondral bones in mutants mineralising at a similar rate to wt fish.
During cartilage degeneration, such as in osteoarthritis, a switch of collagens is commonly reported with a reduction of Type II and increase in Type I collagen, associated with stiffer matrix (41). To test whether loss of Type II collagen led to replacement with Type I, we performed immunostaining in wt and mutant larvae at 5 and 7dpf. In wt fish Type I collagen was present in the jaw joint space, Meckel’s symphasis and at a low level in the cartilage ECM, this pattern was unchanged in mutants (Supplementary Figure 3).
Taken together, these results suggest that reduction in GAGs, calcification and increased Type I collagen do not accompany Type II collagen loss in col11a2 mutants. As a result, the increase in cartilage stiffness observed from AFM cannot be attributed to alterations in these components.
Zebrafish with a col11a2 mutation have altered jaw and joint morphology during development
Humans carrying mutations in Type XI collagen show alterations to craniofacial shape, including midface hypoplasia and micrognathia (42,43). From Type II collagen immunostaining and alizarin red alcian blue staining, we observed that mutant zebrafish also show altered craniofacial morphology (Figures 1B and 2B). At 3dpf there was no significant difference in jaw morphology, but at 5 and 7dpf mutants had significantly shortened, wider jaws (Figure 2C, D), in line with the broader, flatter face shape observed in patients with Stickler syndrome.
As people with mutations in Type XI collagens also display abnormal joint shape (44) and increased susceptibility to osteoarthritis (8), we generated 3D surface models of the joint between the Meckel’s cartilage and the palatoquadrate (jaw joint) at 3, 5 and 7dpf in wt and mutants (Figure 3A). At 3dpf we saw only minor alterations to the joint angle (Figure 3B). However, in mutants at 5 and 7dpf we observed increased Meckel’s cartilage width at both the joint neck and joint head (Figure 3C, D), and a reduction in the gap between the Meckel’s cartilage and palatoquadrate such that the interzone is no longer clearly defined in the renders, likely due to the increased local deposition of Type II collagen (Figure 3B, E). These results show that the abnormal pattern of Type II collagen deposition seen in col11a2 zebrafish mutants at 5 and 7dpf leads to enlarged, less defined joints.
A) Representation of measurements taken of joint neck (red line), joint head (green line) and joint space (white line) (Meckel’s cartilage = light blue, palatoquadrate = dark blue). Orientation compass: A = anterior, L = lateral, M = medial, P = posterior. B) 3D surface renders of jaw joint from confocal images of wt and col11a2-/- at 3, 5 and 7dpf. Red arrowheads = areas of change. C-E) Quantification of joint morphology at (C) joint neck, (D) joint head and (E) joint space (n=3 for all). Student’s unpaired t-tests performed in C, D and E, data is mean with SEM.
Both shape and material properties impact the biomechanical performance of the zebrafish lower jaw
We have previously modelled the biomechanics of zebrafish jaw opening and closure during early ontogeny using Finite Element Analysis (FEA) (39) and shown that paralysis and the accompanying changes to joint shape impact the strain pattern in the developing joint (29). Therefore, we used FEA to model how the changes to shape and material properties observed in col11a2 mutants would affect the biomechanical performance of the lower jaw. Meshes were generated of wt and mutant larvae at 7dpf (meshes shown in Supplementary Figure 4). We applied muscle forces as per Roddy et al (45) and used the material properties established from AFM (Figure 1C).
We first modelled the wt and the mutant jaw shapes using the material properties established from each genotype and modelled a 2 step process for jaw movement with Step 1 denoting jaw closure and Step 2 jaw opening (as per (39,45)) and visualised the maximum principal (EMax) and minimum principal (EMin) strains for jaw opening (Figure 4) and closure (Supplementary figure 5). In the wt model, tensional strains (EMax) are located laterally around the joint and either side of the Meckel’s symphasis, focused on the muscle insertion points with the strain spreading widely through the element. By contrast, in mutants, maximum principal strain is concentrated on the joint interzone, with little spread through the cartilaginous element (note blue colour throughout the cartilage of mutants, c.f. greens and yellows in wt) (Figure 4A, Supplementary videos 1,2). In wt, compressional strains (EMin) are at the Meckel’s symphasis, the medial surface of the anterior MC and on the dorsolateral side of the jaw joint (Figure 4A, Supplementary Figure 5A). In mutants, again, the minimum principal strains are more focal than in wt larvae (Figure 4A, Supplementary Figure 5A). To test whether the change to the strain pattern was predominantly caused by the alteration to the shape of the jaw elements or the changes to YM, we next modelled the effect of mutant properties in the wt shape, and wt properties in the mutant shape (Figure 4B, Supplementary Figure 5B). We observed that changing YM in the wt shape to the mutant values decreased the spread of max and min principal strains, such that the pattern was intermediate between the mutant and wt. Likewise, inserting the wt values for cartilage into the mutant shape lead to an increase in the extent of both tension (EMax) and compression (EMin). However, it did not fully ‘rescue’ the pattern, leading us to conclude that while both shape and material properties play a role in the mechanical performance of the tissue, the effect of shape is greater than that of material properties.
A, B) Finite Element (FE) models of maximum (E. Max) and minimum (E. Min) principal strain during mouth opening in 7dpf wt and col11a2-/-. Red arrowheads denote areas of high strain, black arrowheads show areas of low strain, black asterisks mark jaw joint. A) wt jaw shape with wt material properties and col11a2-/- shape with col11a2-/- material properties. B) wt shape with col11a2-/- material properties and col11a2-/- shape with wt material properties.
Mutation in col11a2 leads to altered chondrocyte cell behaviour
From the FEA we observed a reduction in max and min principal strain in much of the mutant lower jaw cartilage, which corresponded to alterations to chondrocyte behaviour. In wt larvae all cells expressing Type II collagen are located within the cartilage element, however, in mutants we frequently observed chondrocytes located outside the main body of the cartilage element (Supplementary Figure 6A). We quantified the time at which these cells were seen and their frequency across the lower jaw elements of wt and mutant larvae. Prior to 5dpf these spurs, which resemble hereditary multiple exostoses (46), are not observed (Supplementary Figure 6B). However, at 5dpf and 7dpf they are present in the Meckel’s cartilage and ceratohyal but are not seen in the palatoquadrate (Supplementary Figure 6C).
col11a2 zebrafish mutants show impaired jaw function
As patients with Stickler syndrome suffer from joint hypermobility (47), and as col11a2 zebrafish mutants show aberrant joint morphology, we looked at jaw function at 5dpf. Zebrafish have two joints within the lower jaw and make distinct movements for feeding and breathing (48). By taking movies and quantifying jaw movement, we observed that mutants make significantly fewer total movements than wt (Figure 5B, Supplementary videos 3,4). This was due to a reduction in the number of movements involving the jaw joint, as we observed no significant difference in the frequency of movements involving the buccal joint (Figure 5B). However, mutant zebrafish show an increased range of motion at the buccal joint, which appears to dislocate (Figure 5A, C). To rule out the possibility that this change to movement was caused by altered muscle patterning, we quantified the number of slow twitch fibres in the jaw at 5dpf and saw no difference in fibre number between wt and mutants (Supplementary Figure 7). Taken together this suggests that the alterations to joint shape observed in col11a2 mutants are the cause of abnormal joint function.
A) Stills from high speed movies show jaw movement in wt and col11a2-/- B, C) Analysis of (B) total jaw movements and (C) range of movement at two locations shown in (A): red line = mouth, blue line= buccal joint (n= 7 for all). Student’s unpaired t-tests performed for B and C, data is mean with SEM.
Premature OA is observed in adult col11a2 heterozygous fish
Due to the abnormalities in joint shape, mechanical performance and function in mutants, and since aberrant joint loading is highly associated with OA risk (49), we wanted to test whether adult mutants would develop premature osteoarthritis. To address this question, we analysed 1-year old heterozygous fish (col11a2+/-) and wt siblings using micro-computed tomography (μCT). Craniofacial abnormalities were observed in col11a2+/-, including jaw protrusion and hypoplasia of the fronto-nasal bone (Figure 6A). Changes in joint shape were observed in col11a2+/- accompanied by narrowing of the inter-joint space (Figure 6B). To identify the histopathological changes related to OA, we stained wt and col11a2+/- joint sections for Alcian Blue and H&E (Figure 6C). While in wt sections a defined cartilaginous layer lines the joint, in col11a2+/- the cartilage shows signs of degradation. OARSI grading of the sections showed 6 in the col11a2+/-; which is characterised by deformation and change in the contour of the articular surface (Figure 6C). Osteophytes were not observed. We analysed collagen organisation using PicroSirius red staining. In wt jaws, the cartilaginous layer at the joint shows organised collagen fibres with a distinct orientation from those of the underlying bone (Figure 6D). However, in the col11a2+/- the transition from cartilage to bone is lost and the overall organization is perturbed (Figure 6D). This demonstrates that the joint changes observed in larval col11a2 mutants lead to early onset of OA in adults.
A, B) 3D renders from μCTs of 1-year old wt and col11a2 heterozygous mutant (col11a2+/-). A) Yellow arrow = jaw joint, dashed green arrow = region of jaw protrusion in col11a2+/-, green arrow = region of hypoplasia in fronto-nasal skeleton. B) Higher magnification image of joint region where dashed yellow line = inter-joint space. C, D) Paraffin sections of the jaw joint stained with (C) Alcian blue and Haematoxylin/Eosin and (D) PicroSirius red. Dashed black line = cartilage layer, black arrows = underlying bone, dashed white line = cartilage, white arrow = bone (green). Scale bar = 50μm.
Discussion
Mutations in the Type XI collagen genes col11a1 and col11a2 have previously been linked to numerous skeletal dysplasias, such as Stickler syndrome and Fibrochondrogenesis, which are associated with cartilage destabilisation, and abnormal skeletal shape and properties. Here, we describe the impact of loss of col11a2 in zebrafish and show changes to ECM composition, material properties, craniofacial shape, mechanical load, chondrocyte behaviour, and joint function in larval and adult fish.
Type XI collagen is important for the protection of Type II collagen from degradation (50); our data suggest that, while transcription and secretion of Type II collagen is unaffected, the assembly of Type II collagen fibrils may be altered in mutants, making them more susceptible to degradation. This idea is given weight by the identification of fragments of Type II positive material seen surrounding the cartilage elements. What happens to those degraded collagen fragments is still unclear. Potentially, they may be cleared by the phagocytic cells of the innate immune system either with a rapid resolution, or alternatively, continued accumulation of these fragments could lead to the low-level inflammation associated with osteoarthritis (51,52). Loss or breakdown of Type II collagen also occurs as the chondrocytes mature, such that the matrix between the chondrocytes almost completely lacks Type II collagen, while the matrix of the perichondrium is relatively preserved. We have tested effects of col11a2 loss on the material properties of cartilage and bone, and our data shows an increase in YM in both tissues, with the greatest difference seen in mature chondrocytes. It may be noted that Young’s modulus for zebrafish cartilage is higher than that from other species (4.15MPa in fish vs 0.45Mpa in human articular cartilage (53)). One likely explanation is the variation in relative ratio of cells to matrix during development and across species in evolution. In mature human articular cartilage the ratio is approximately 10:90 cells to matrix compared to 80:20 in zebrafish (54). The higher YM in mutants was not explained by increased calcification, accumulation of Type I collagen or loss of GAG. In rodent models increased matrix stiffness has been described as chondrocytes mature in the growth plate (55,56). The stiffness of collagen matrix is controlled by several factors including fibre diameter and the density of intra-fibrillar cross-links, and abnormalities in collagen fibrillar assembly have been related to changes to mechanical properties of the cartilage during progression of OA (57) and ageing (58).
It has previously been reported that patients with Stickler syndrome develop premature OA (1) but the mechanism by which this occurs is unclear. We and others have previously shown that, despite living in an aquatic environment, zebrafish can also develop alterations to the joint that strongly resemble OA (59,28) Interestingly, we see premature development of osteoarthritis in col11a2 heterozygous adult zebrafish. This is manifested by abnormal collagen organisation, degeneration of joint cartilage and loss of joint space. During OA, proteoglycans are lost from the cartilage prior to the degradation of the collagen network in the extracellular matrix (2). This change to the organisation and content of collagen in the cartilage leads to changes in its material properties (3), including its stiffness and tensile strength (4). It has previously been demonstrated that in OA, cartilage stiffness is often reduced (17,60), while we saw a dramatic increase in cartilage matrix stiffness in the col11a2 mutants these measurements were taken from larvae. We saw increased YM in adult bone, albeit less dramatically than in the cartilage. Potentially, stiffer bone could exacerbate OA pathogenesis; as subchondral bone thickening accelerates the degradation of articular cartilage (61). Alternatively, and perhaps more likely, changes to joint loading from the abnormal shape and function throughout life may be the driver for the development of pathogenic osteoarthritic changes in the joint.
As joint mechanical performance is impacted by its shape and the material properties of the tissues, we explored the relative impact of each by testing the impact of altering material properties in the wild type and mutant shapes. From this we deduced that while both contribute to the strain pattern, the larger impact comes from joint architecture. However, questions remain to the exact sequence of events; are the increases in YM in immature chondrocytes sufficient to drive local changes to cell behaviour within the joint? If so subtle changes to joint morphology, could impact joint mechanics upon onset of function, leading to further, more significant changes to skeletal cell behaviour. Movement of joints has been shown to be required for their correct specification in the majority of joint types in all species studied (62–66). Interestingly, at the earliest stages we studied (3dpf), prior to the onset of joint movement, the mutants are barely distinguishable from wild types, despite the col11a2 gene being expressed throughout the cartilage from 2dpf. Following the onset of movement changes between wild type and mutants become more pronounced, these include the degradation of Type II collagen from the mature matrix, and the loss of the joint space, suggesting premature differentiation of the immature cells of the interzone. Alternatively, it could represent a failure to maintain gdf5 signalling locally; it has been shown that there is a requirement for the continued influx of Gdf5 positive cells for correct joint specification (67).
It is likely that by changing the mechanical performance of the joint, that mechanosensitive genes will be differentially activated, and these likely control the cellular changes we describe. Candidates that could be differentially activated in the mutants could include the Piezo ion channels which have been shown to play a role in OA (68). Another candidate could be the YAP pathway; YAP is implicated in negative control of chondrogenesis (69,70). Or the genes in the Wnt signalling pathway. The Wnt pathway has been implicated in developmental skeletal mechanosensation in mice, chicks (71) and zebrafish (72), and could potentially be acting in combination with BMP regulatory genes such as Smurf1 (73). We have shown in zebrafish that wnt16 is downstream of mechanical strains in the developing joint, and controls chondrocyte proliferation and migration. Wnt16 is also linked to hip geometry (74) altered cortical bone thickness (75,76) the response of chondrocytes to injury and to osteoarthritis (77,78).
Following the onset of movement, we also see the appearance of cells located outside the cartilage anlage, which bear some resemblance to multiple hereditary extoses (MHE). Stickler syndrome is associated with MHEs (79). It has been reported in a zebrafish model that the development of MHE is driven by changes to the matrix from loss of the Extosin genes, that, while dispensable for early chondrocyte differentiation are required for chondrocyte maturation, hypertrophy and intercalation and which encode genes lead to matrix sulfation (46). Potentially, the loss of Type II collagen in the col11a2 mutants could perturb sulfation. Alternatively, these cells could fail to intercalate then be extruded due to altered joint function, as paralysis has been shown to control chondrocyte intercalation in zebrafish (80).
Taken together our findings show that loss of col11a2 in zebrafish leads to changes to matrix phenotype, and cell behaviour that impact the biomechanical and functional performance of the developing joint. By making use of the detailed dynamic imaging unique to small translucent models like the zebrafish we were able to follow the alterations to the developing skeleton at cellular resolution, identifying changes to cell behaviour that go some way to explaining how loss of a relatively minor collagen subtype can have such a profound effect on the human skeleton in diseases such as Stickler syndrome and Fibrochondrogenesis.
The authors declare no competing interests. EL, KR and EK carried out the molecular lab work, participated in data analysis, participated in the design of the study and drafted the manuscript; JA generated the FE models; RH performed AFM; CLH conceived of the study, designed the study, coordinated the study and helped draft the manuscript. All authors gave final approval for publication.
Funding
CLH and EK were funded by Arthritis Research UK grants 21211 and 19947. KR was funded by the MRC (MR/L002566/1). EL is funded by a Wellcome Trust Dynamic Molecular Cell Biology PhD programme. PeakForce AFM was carried with equipment funded by the EPSRC (EP/K035746/1).
Acknowledgements
The authors would like to thank Stephen Cross and the Wolfson Biomaging facility staff for help with image acquisition and analysis.
References
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- 17.↵
- 18.↵
- 19.↵
- 20.↵
- 21.↵
- 22.↵
- 23.↵
- 24.↵
- 25.↵
- 26.
- 27.↵
- 28.↵
- 29.↵
- 30.↵
- 31.↵
- 32.↵
- 33.↵
- 34.↵
- 35.↵
- 36.↵
- 37.↵
- 38.↵
- 39.↵
- 40.↵
- 41.↵
- 42.↵
- 43.↵
- 44.↵
- 45.↵
- 46.↵
- 47.↵
- 48.↵
- 49.↵
- 50.↵
- 51.↵
- 52.↵
- 53.↵
- 54.↵
- 55.↵
- 56.↵
- 57.↵
- 58.↵
- 59.↵
- 60.↵
- 61.↵
- 62.↵
- 63.
- 64.
- 65.
- 66.↵
- 67.↵
- 68.↵
- 69.↵
- 70.↵
- 71.↵
- 72.↵
- 73.↵
- 74.↵
- 75.↵
- 76.↵
- 77.↵
- 78.↵
- 79.↵
- 80.↵